| αSMA | Alpha Smooth Muscle Actin |
| BMDCs | Bone Marrow Derived Cells |
| CAF | Cancer Associated Fibroblast |
| CCL2 | Chemokine (C-C motif) Ligand 2 |
| CCL21 | Chemokine (C-C motif) Ligand 21 |
| CCR7 | Chemokine (C-C motif) Receptor Type 7 |
| COX2 | Cyclooxygenase-2 |
| CSF-1 | Colony Stimulating Factor 1 |
| CTC | Circulating Tumor Cell |
| CXCR4 | Chemokine (C-X motif) receptor 4 |
| ECM | Extracellular Matrix |
| EGFR | Epidermal Growth Factor Receptor |
| EMT | Epithelial to Mesenchymal Transition |
| G-CSF | Granulocyte-Colony Stimulating Factor |
| HIF-1α | Hypoxia Inducible Factor-1 Alpha |
| HPCs | Hematopoietic Progenitor Cells |
| IL-6/32 | Interleukin–6 or 32 |
| LOX | Lysyl Oxidase |
| LOXL | Lysyl Oxidase-Like |
| Ly6C | Lymphocyte Antigen 6 Complex |
| p38 MAPK | p38 Mitogen-Activated Protein Kinase |
| MDSCs | Myeloid Derived Suppressor Cells |
| MET | Mesenchymal-Epithelial Transition |
| MIP2 | Macrophage Inflammatory Protein–2 |
| MMP2/9 | Matrix Metalloproteinase 2 or 9 |
| NF-κB | Nuclear Factor Kappa-light-chain-enhancer of activated B cells |
| PDGFR-β | Platelet Derived Growth Factor Receptor Beta |
| PD-L1 | Programmed Cell Death Ligand 1 |
| PGE2 | Prostaglandin E2 |
| SDF-1 | Stromal Derived Factor 1 |
| S100A8/9 | S100 Calcium Binding Protein A8/9 |
| Src-FAK | Steroid Receptor Co-activator-Focal Adhesion Kinase |
| TDSFs | Tumor Derived Soluble Factors |
| TDEs | Tumor Derived Exosomes |
| TGFβ | Transforming Growth Factor Beta |
| TNFα | Tumor Necrosis Factor Alpha |
| VEGFR-1 | Vascular Endothelial Growth Factor Receptor-1 |
| VLA-4 | Very Late Antigen-4 |
| ZO-1 | Zonula Occludens-1 |